Patent issues relating to hybrid drugs

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.18, Iss.10, 2008-10, pp. : 1191-1194

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cancer cachexia: drugs in the patent literature

By Bossola Maurizio Pacelli Fabio Doglietto Giovan Battista

Expert Opinion on Therapeutic Patents, Vol. 18, Iss. 7, 2008-07 ,pp. : 739-757

Informa Healthcare

Access to resources Recommend Favorite

Hybrid Drugs for Malaria

Current Pharmaceutical Design, Vol. 15, Iss. 25, 2009-09 ,pp. : 2970-2985

Bentham Science Publishers

Access to resources Recommend Favorite

Paediatric issues relating to the pharmacotherapy of allergic rhinitis

By Schenkel E.J.

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 7, 2000-12 ,pp. : 1289-1306

Informa Healthcare

Access to resources Recommend Favorite

Revocation of European patent for neural progenitors highlights patent challenges for inventions relating to human embryonic stem cells

By Rigby Barbara

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 11, 2013-11 ,pp. : 1395-1398

Informa Healthcare

Access to resources Recommend Favorite

Coumarin-based drugs: a patent review (2008 – present)

By Kontogiorgis Christos Detsi Anastasia Hadjipavlou-Litina Dimitra

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 4, 2012-04 ,pp. : 437-454

Informa Healthcare

Access to resources Recommend Favorite